Cargando…
The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death
BACKGROUND: Identifying the patients with hypertrophic cardiomyopathy (HCM) in whom the risk of sudden cardiac death (SCD) justifies the implantation of a cardioverter-defibrillator (ICD) in primary prevention remains challenging. Different risk stratification and criteria are used by the European a...
Autores principales: | Freitas, Pedro, Ferreira, António Miguel, Arteaga-Fernández, Edmundo, de Oliveira Antunes, Murrilo, Mesquita, João, Abecasis, João, Marques, Hugo, Saraiva, Carla, Matos, Daniel Nascimento, Rodrigues, Rita, Cardim, Nuno, Mady, Charles, Rochitte, Carlos Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694533/ https://www.ncbi.nlm.nih.gov/pubmed/31412875 http://dx.doi.org/10.1186/s12968-019-0561-4 |
Ejemplares similares
-
Prevention of Sudden Death in Hypertrophic
Cardiomyopathy
por: Arteaga-Fernández, Edmundo, et al.
Publicado: (2018) -
Late gadolinium enhancement is compatible with advanced age in hypertrophic cardiomyopathy: implications for risk stratification of sudden death
por: Chan, Raymond H, et al.
Publicado: (2012) -
Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy
por: Ismail, Tevfik F, et al.
Publicado: (2013) -
Segmental late gadolinium enhancement and gadolinium extracellular volume in hypertrophic cardiomyopathy
por: Levine, Jonathan M, et al.
Publicado: (2016) -
Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy:
What has Changed in The Guidelines?
por: Reis, Liliana, et al.
Publicado: (2018)